Jeffrey H. Newcorn

Jeffrey H. Newcorn

Icahn School of Medicine at Mount Sinai
USA

Dr. Jeffrey Newcorn received his medical degree from the University of Rochester in New York. He completed his general psychiatry and child and adolescent psychiatry training at Tufts-New England Medical Center, Boston. Dr. Newcorn is currently associate professor of psychiatry and pediatrics, and director, Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai. He is also the director of Pediatric Psychopharmacology for the Mount Sinai Health System.
Dr. Newcorn is a highly regarded clinician – researcher with special expertise in the areas of ADHD, aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology, whose academic work spans both clinical and translational topics. He has been a member of the steering committee of the NIMH-funded multicenter study “Multimodal Treatment of Children with ADHD (MTA).” He was the primary investigator on an NIMH-funded ADHD Research Infrastructure Network devoted to understanding the neurobiology of ADHD, and has been (and currently is) the principal investigator or co-investigator on several NIMH-funded and industry-funded grants that examine the clinical presentation and neurobiological basis of ADHD and its treatment.
Dr. Newcorn is an internationally recognized educator and mentor, and an editorial board member of several leading child psychiatry and psychology journals. He directs an active clinical trials program, and has studied many of the newer medication treatments for ADHD. He has published over 275 peer-reviewed articles and book chapters on these and related subjects. Dr. Newcorn’s most recent research focuses on the clinical and neurobiological basis of differential response to ADHD treatments, utilizing data obtained from clinical, neuropsychological, pharmacogenetic and fMRI measures.
Dr. Newcorn has held positions in several US and international organizations. He is a founding member of the board of directors of the American Professional Society for ADHD and Related Disorders (APSARD), and has served as the chair of the APSARD Program Committee for the past three years. He is also Chair of the Advisory Board of the Klingenstein Third Generation Foundation.